Armatus Bio
Developer of vectorized therapeutics designed to target and silence specific genes. The company uses genetic science and bioengineering to deliver therapies specifically targeting affected tissues in ...
Valuation
$0
Share Price
N/A
Total Raised
$14.8M
Last Round
N/A